Invokana and Nasonex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Invokana (canagliflozin) and Nasonex (mometasone furoate monohydrate). Common drug interactions include headache among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Invokana and Nasonex. It is created by eHealthMe based on reports of 89 people who take the same drugs from the FDA, and is updated regularly.

What is Invokana?

Invokana has active ingredients of canagliflozin. It is often used in diabetes. eHealthMe is studying from 29,937 Invokana users. Check the latest studies of Invokana.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

On Jul, 16, 2026

89 people who take Invokana and Nasonex together, and have interactions are studied.

What are the common drug interactions of Invokana and Nasonex, by gender? *:

female:

Headache (pain in head)
Immune thrombocytopenic purpura (destruction of blood platelets due to the presence of antiplatelet auto antibodies)
Mobility decreased (ability to move is reduced)
Platelet count decreased
Rib fracture
Blood glucose increased
Urinary tract infection
Alopecia (absence of hair from areas of the body)
Anxiety
Nausea (feeling of having an urge to vomit)

male:

Chronic kidney disease
Pancreatitis (inflammation of pancreas)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Blood thyroid stimulating hormone decreased
Cataract (clouding of the lens inside the eye)
Cellulitis (infection under the skin)
Erectile dysfunction
Gas gangrene (bacterial infection that produces gas within tissues)
Groin abscess (pus in groin)
Groin pain

What are the common drug interactions of Invokana and Nasonex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Blood glucose increased
Drug ineffective
Impaired gastric emptying
Pancreatitis (inflammation of pancreas)

40-49:

Chronic kidney disease
Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Blood glucose increased
Blood thyroid stimulating hormone decreased
Erectile dysfunction
Influenza
Injection site abscess
Injection site pain
Injection site reaction

50-59:

Testicular pain (pain in testes)
Dysgeusia (disorder of the sense of taste)
Abdominal pain
Anxiety
Asthenia (weakness)
Back pain
Blood glucose decreased
Blood glucose increased
Chest pain
Cold sweat

60+:

Asthma
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Pulmonary embolism (blockage of the main artery of the lung)
Urinary tract infection
Blood glucose increased
Erythema (redness of the skin)
Hair colour changes
Hair disorder
Hyperchlorhydria (gastric acid levels are higher in stomach)
Rebound effect (take-back effect)

What are the existing conditions these people have? *

Type 2 Diabetes: 42 people, 47.19%
Asthma: 31 people, 34.83%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 24 people, 26.97%
Pain: 13 people, 14.61%
High Blood Cholesterol: 11 people, 12.36%
Hypersensitivity: 10 people, 11.24%
Muscle Spasms (muscle contraction): 9 people, 10.11%
High Blood Pressure: 9 people, 10.11%
Cardiac Disorder: 9 people, 10.11%
Neuropathy Peripheral (surface nerve damage): 7 people, 7.87%

* Approximation only. Some reports may have incomplete information.

Do you take Invokana and Nasonex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously